Glenn D. Steele Jr. named chair of City of Hope board of directors

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Glenn D. Steele Jr. was elected board chair of City of Hope, effective June 1.

Steele joined the City of Hope Board of Directors in January 2016. Prior to becoming chair, he was chair of the Executive Compensation and Governance Committee from 2018-2020.

Selwyn Isakow, founder and chief executive officer of The Oxford Investment Group, is the immediate past chair.

His investigations have focused on the cell biology of gastrointestinal cancer and pre-cancer and, most recently, on innovations in health care delivery and financing.

Steele serves as chairman of GSteele Health Solutions, an independently-operated venture launched to help health care organizations create value and improve quality. He is the former chairman of xG Health Solutions and former president and chief executive officer of Geisinger Health System, an integrated health services organization recognized for its innovative use of the electronic health record and the development and implementation of care models.

Steele is past chairman of the American Board of Surgery, and serves on for-profit and not-for-profit boards and national committees, including vice chair of Health Transformation Alliance, Bucknell University Board of Trustees as an emeritus trustee, Stanford Board of Fellows, Peterson Center on Healthcare Advisory Board, and serves as an adviser on the private equity firms of General Atlantic and LRVHealth.

Steele is a member of the National Academy of Medicine and has served as the dean of the Biological Sciences Division and the Pritzker School of Medicine and vice president for medical affairs at University of Chicago, as well as the Richard T. Crane Professor in the Department of Surgery. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School.

Table of Contents

YOU MAY BE INTERESTED IN

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login